Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: August 2009

Budesitan

04 August 2009 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport-declaration required. Active ingredient: Budesonide 0.5mg/2ml, 1mg/2ml. Description: White to off-white suspension. Presentation: 0.5mg/2ml-20, €25.49; 1mg/2ml-20, €36.78. Indication: Persistent bronchial asthma in patients where use of a pressurised inhaler or dry powder... Read more

Gabapentin Teva

04 August 2009 | New Products

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Gabapentin 600mg, 800mg. Description: White to off-white, oval shaped, bevelled edged, film-coated tablets engraved 7173 (600mg) or 7174 (800mg) on one side and 93 on the other. Presentation:... Read more

Mycamine

04 August 2009 | New Products

Company: Astellas Pharma Co. Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Micafungin (as sodium), 50mg, 100mg. Description: Vial containing white compact powder for solution for infusion. Presentation: 50mg-1, €297.97; 100mg-1, €496.97. Indications: Invasive candidiasis; prophylaxis of Candida infection in... Read more

Pabal

04 August 2009 | New Products

Company: Ferring Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Carbetocin 100mcg/ml. Description: Clear colourless solution for injection in ampoules. Presentation: 5 ×1ml ampoules, €135.33. Indications: Prevention of uterine atony following delivery of the infant by Caesarean section under... Read more

Pravastatin sodium

04 August 2009 | New Products

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pravastatin (Na+) 10mg, 20mg, 40mg. Description: Respectively, pink, light yellow, or light green round tablet, 93 on one side and 771, 7201 or 7202 on the other. Presentation:... Read more

Prindace

04 August 2009 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Perindopril tert-butylamine 4mg, 8mg. Description: 4mg: White, rod-shaped tablet, scored on both edges. The tablet can be divided into equal halves. 8mg: White, round convex tablet. Presentation: 4mg-30,... Read more

Zolepant

04 August 2009 | New Products

Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg (as sodium sesquihydrate). Description: Light brownish yellow, oval, slightly biconvex tablets. Presentation: 20mg-28, €10.82; 40mg-28, €20.04. Indications: Zolepant 20mg: Treatment of mild reflux disease and associated... Read more

Romep

04 August 2009 | New Presentations

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Omeprazole 10mg, 20mg, 40mg. Description: Hard gastro-resistant capsules containing yellowish brown granules.10mg: light brown marked OME10. 20mg: White marked OME20. 40mg: White cap, light brown body, marked OME40. Presentation:... Read more

Transfer of Prostap Marketing Authorisations to Takeda UK

04 August 2009 | New this Month

Wyeth Pharmaceuticals wish to advise of the transfer of the Marketing Authorisations for Prostap 3 and Prostap SR from Wyeth Pharmaceuticals Ltd to Takeda UK Ltd. This change is effective immediately. If you have any supply enquiries, requests for medical... Read more

Codalax Suspension and Codalax Forte Suspension temporarily out of stock

04 August 2009 | Discontinued Products

Mundipharma Pharmaceuticals Ireland would like to inform you that due to technical issues Codalax 200mg/25mg per 5ml suspension and Codalax Forte 1000mg/75mg per 5ml suspension will soon be temporarily out of stock. Supply of Codalax Forte Suspension ceased on 31st... Read more

Dovonex 60g Cream discontinued

04 August 2009 | Discontinued Products

LEO Pharma wishes to announce that Dovonex Cream 60g will be discontinued from August 2009. This discontinuation is not due to any safety or quality issues with Dovonex cream, therefore pharmacists and patients may continue to dispense or use Dovonex... Read more

Buspar discontinued in December 09

04 August 2009 | Discontinued Products

Bristol-Myers Squib Pharmaceuticals Ltd has decided to discontinue Buspar 5mg and 10mg from the end of December 2009. The decision has been taken for operational reasons and affects all European markets. Alternative treatments are available. Should you have any queries,... Read more

Nurofen Metlets discontinued

04 August 2009 | Discontinued Products

Reckitt Benckiser Ireland Ltd wish to advise you that Nurofen Meltlets is no longer available in Ireland. The product has been discontinued from the Irish market for rationalisation reasons. For any further queries, please contact Reckitt Benckiser on (01) 6305429.... Read more

Viskaldix and Visken discontinued

04 August 2009 | Discontinued Products

Novartis Ireland Ltd announce the discontinuation of Viskaldix tablets, pack size 28s and Visken 5mg tablets, pack sizes 50s, 56s & 100s from 29th September 2009. For further information please contact Novartis on (01) 2601255.... Read more

Nexium IV licensed to reduce the risk of peptic ulcer rebleeding

01 August 2009 | New Clinical Evidence

Nexium IV (esomeprazole) has been approved in Ireland for prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. Currently, it is the only proton pump inhibitor (PPI) to be licensed in Ireland for this condition. Nexium... Read more

Interaction between Clopidogrel and PPIs

01 August 2009 | Irish Medicines Board

IMB Guidance on possible interaction between Clopidogrel and Proton Pump Inhibitors Clopidogrel is an antiplatelet drug authorised for the prevention of atherothrombotic events in patients suffering from myocardial infarction, ischaemic stroke or acute coronary syndrome, or those at risk of... Read more